The blogosphere is alive with the news that a federal court has overturned a patent held by Myriad Genetics for the BRCA1 and BRCA2 breast cancer genes. The company patented the genes in the 1990s and then invented a test to identify some of the mutations, according to the Los Angeles Times blog Booster Shots. "You might be asking yourself how a company could get a patent on a gene, which isn’t a man-made invention.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.